Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood glucose changes after lidocaine with versus without epinephrine in well-controlled type 2 diabetes during dental extraction
IRCT20210306050606N2Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lidocaine and epinephrine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Blood glucose changes following local anesthesia with and without epinephrine. Started Jun 2024; status: completed.
02
Drugs
lidocaineepinephrine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20210306050606N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210306050606N2.